학술논문
The significant improvement in ovarian PCOS syndrome using hydralazine and alendronate aromatase inhibitor FDA-approved drugs in Wistar rat models
Document Type
Article
Author
Source
In Biomedicine & Pharmacotherapy May 2024 174
Subject
Language
ISSN
0753-3322